A case report reveals pyoderma gangrenosum as an early sign of inflammatory bowel disease, suggesting careful diagnostics for these manifestations.
Approximately 50% of patients with inflammatory bowel disease (IBD) exhibit extraintestinal manifestations, among which skin and mucosal lesions are common. However, pyoderma gangrenosum occurs in only 1%‐2% of IBD patients. We report the case of a 23‐year‐old male patient who was admitted to the hospital with pyoderma gangrenosum that was unresponsive to conventional treatments. The patient did not exhibit any gastrointestinal symptoms. We conducted diagnostic investigations, excluding causes such as infections, vascular occlusions, and systemic diseases. The patient did not respond to systemic antibiotic therapy and local care. With mild thickening of the colon wall observed on a CT scan, we decided to perform a colonoscopy, which revealed lesions suggestive of chronic ulcerative colitis. Histopathological examination of the colon tissue confirmed the diagnosis. With the diagnosis of early onset chronic ulcerative colitis presenting with extraintestinal manifestations, we decided to treat the patient with the biological drug infliximab. After 3 months of treatment, the pyoderma gangrenosum lesions healed. In summary, this clinical case indicates that pyoderma gangrenosum can be an initial and rare manifestation of IBD.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: